Physician profile
Daniel Cavazos
NPI 1083683460
$11,860.89
in general payments reported to CMS, 2019-2025
25 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,699 · 2020: $1,840 · 2021: $1,057 · 2022: $658 · 2023: $1,070 · 2024: $470 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902 · Travel and Lodging: $392 · Consulting Fee: $175 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,902.05 |
| Travel and Lodging | $392.36 |
| Consulting Fee | $175.00 |
| Education | $136.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,135.39 | 2019-2020 | |
| Stryker Corporation | $2,854.70 | 2019-2025 | 1788, 1688, Alphavent |
| Exactech, INC. | $1,740.67 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $1,110.41 | 2023-2025 | Rosa, Persona, Comprehensive Shoulder System |
| Amgen INC. | $959.53 | 2019-2025 | Evenity, Prolia, Prolia |
| Depuy Synthes Sales INC. | $384.41 | 2019-2025 | Motoband, Fms, Milagro |
| Fortis Surgical, LLC | $327.51 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $185.28 | 2022-2023 | Xtampza |
| Smith+Nephew, INC. | $167.79 | 2019-2020 | |
| Pacira Therapeutics, INC. | $165.73 | 2020-2021 | |
| Alphatec Spine, INC | $152.31 | 2024 | Other - Miscellaneous |
| Siemens Medical Solutions USA, INC. | $128.61 | 2021 | |
| Fidia Pharma USA INC. | $126.30 | 2019-2022 | |
| Cerapedics INC. | $93.58 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Bioventus LLC | $84.07 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $62.20 | 2021 | |
| Engage Uni, LLC | $40.00 | 2020 | |
| Nevro Corp. | $23.39 | 2023 | Senza |
| Pacira Pharmaceuticals Incorporated | $22.28 | 2019 | |
| Vericel Corporation | $20.91 | 2025 | Maci |
| Heron Therapeutics, INC. | $18.98 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.51 | 2021 | |
| Convatec INC. | $14.62 | 2019 | |
| Sanara Medtech INC. | $13.42 | 2021 | |
| Allergan, INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cavazos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.